Literature DB >> 14699422

Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis.

P Sklar1, M T Pato, A Kirby, T L Petryshen, H Medeiros, C Carvalho, A Macedo, A Dourado, I Coelho, J Valente, M J Soares, C P Ferreira, M Lei, A Verner, T J Hudson, C P Morley, J L Kennedy, M H Azevedo, E Lander, M J Daly, C N Pato.   

Abstract

Schizophrenia is a common psychiatric disorder with a complex genetic etiology. To understand the genetic basis of this syndrome in Portuguese Island populations, we performed a genome-wide scan of 29 families with schizophrenia, which identified a single region on 5q31-5q35 with strong linkage (NPL=3.09, P=0.0012 at D5S820). Empirical simulations set a genome-wide threshold of NPL=3.10 for significant linkage. Additional support for this locus in schizophrenia comes from higher-density mapping and mapping of 11 additional families. The combined set of 40 families had a peak NPL=3.28 (P=0.00066) at markers D5S2112-D5S820. These data and previous linkage findings from other investigators provide strong and consistent evidence for this genomic region as a susceptibility locus for schizophrenia. Exploratory analyses of a novel phenotype, psychosis, in families with schizophrenia and bipolar disorder detected evidence for linkage to the same markers as found in schizophrenia (peak NPL=3.03, P=0.0012 at D5S820), suggesting that this locus may be responsible for the psychotic symptoms observed in both diseases. Molecular Psychiatry (2004) 9, 213-218. doi:10.1038/sj.mp.4001418 Published online 30 December 2003

Entities:  

Mesh:

Year:  2004        PMID: 14699422     DOI: 10.1038/sj.mp.4001418

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  31 in total

1.  Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22.

Authors:  F A Middleton; M T Pato; K L Gentile; C P Morley; X Zhao; A F Eisener; A Brown; T L Petryshen; A N Kirby; H Medeiros; C Carvalho; A Macedo; A Dourado; I Coelho; J Valente; M J Soares; C P Ferreira; M Lei; M H Azevedo; J L Kennedy; M J Daly; P Sklar; C N Pato
Journal:  Am J Hum Genet       Date:  2004-04-01       Impact factor: 11.025

2.  Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

Authors:  Kyu Young Lee; Eun-Jeong Joo; Yong Ick Ji; Duk-Hwan Kim; Joo Bae Park; In-Won Chung; Sang Ick Lee; Yeon Ho Joo; Yong Min Ahn; Joo Yun Song; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

3.  FBXL21 association with schizophrenia in Irish family and case-control samples.

Authors:  Xiangning Chen; Xu Wang; Cuie Sun; Qi Chen; F Anthony O'Neill; Dermot Walsh; Ayman Fanous; Kenneth S Kendler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

4.  ErbB4 reduces synaptic GABAA currents independent of its receptor tyrosine kinase activity.

Authors:  Robert M Mitchell; Megan J Janssen; Irina Karavanova; Detlef Vullhorst; Katrina Furth; Anthony Makusky; Sanford P Markey; Andres Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 5.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

6.  Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.

Authors:  Erika Pedrosa; Radu Stefanescu; Benjamin Margolis; Oriana Petruolo; Yungtai Lo; Karen Nolan; Tomas Novak; Pavla Stopkova; Herbert M Lachman
Journal:  Schizophr Res       Date:  2008-05-27       Impact factor: 4.939

7.  The genomic psychiatry cohort: partners in discovery.

Authors:  Michele T Pato; Janet L Sobell; Helena Medeiros; Colony Abbott; Brooke M Sklar; Peter F Buckley; Evelyn J Bromet; Michael A Escamilla; Ayman H Fanous; Douglas S Lehrer; Fabio Macciardi; Dolores Malaspina; Steve A McCarroll; Stephen R Marder; Jennifer Moran; Christopher P Morley; Humberto Nicolini; Diana O Perkins; Shaun M Purcell; Mark H Rapaport; Pamela Sklar; Jordan W Smoller; James A Knowles; Carlos N Pato
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-05-03       Impact factor: 3.568

Review 8.  Regulation of neural circuit formation by protocadherins.

Authors:  Stacey L Peek; Kar Men Mah; Joshua A Weiner
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

9.  Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Authors:  Parisa Afshari; Marina Myles-Worsley; Ori S Cohen; Josepha Tiobech; Stephen V Faraone; William Byerley; Frank A Middleton
Journal:  Mol Neuropsychiatry       Date:  2015-07-08

10.  Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders.

Authors:  Joseph Gabriele; Giuseppe F Pontoriero; Nancy Thomas; Christy A Thomson; Kevin Skoblenick; Zdenek B Pristupa; Ram K Mishra
Journal:  Cell Stress Chaperones       Date:  2009-03-12       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.